Azafaros
PrivateLast Round
Series B
May 13, 2025
Total Funding Raised
$174.14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Azafaros operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Series B round in May 2025.
Azafaros is a biopharmaceutical company developing disease-modifying therapeutics for rare lysosomal storage disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Azafaros Comparables
Compare Azafaros with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IntraBio | 84% | |
| RougeTx | 79% | |
| Mandos | 79% |
For institutional investors. Book with your work email.
Azafaros Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 13, 2025 | ||||
| Series A | Feb 6, 2020 | ||||
| Seed | Jul 23, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Azafaros Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pictet Group | Series B |
| Asahi Kasei Pharma Venture Capital | Series B |
| BioMedPartners | Series B, Series A |
| Asahi Kasei Therapeutics Venture Capital | Series B |
| Forbion | Series B, Series A |
| Seroba Life Sciences | Series B |
| Forbion Ventures | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 204% MoM, reaching 3.9K.
- Jan 8, 2026
Will present at J.P. Morgan's 44th Annual Healthcare Conference.
For institutional investors. Book with your work email.
Azafaros Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Azafaros's valuation, stock price, and market status.
Is Azafaros a public or private company?
Azafaros is a private company.
What is the current stock price of Azafaros?
Azafaros is a private company, so its shares have no public market price. Caplight tracks Azafaros's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Azafaros worth (valuation)?
Valuation information for Azafaros is not publicly available.
Can I buy Azafaros stock?
Azafaros shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Azafaros's last funding round?
Azafaros's most recent funding round was Series B on May 13, 2025.
Who are the main investors in Azafaros?
Key investors in Azafaros include Forbion, BioGeneration Ventures, Jeito Capital.
Will Azafaros IPO soon?
No public IPO plans have been announced for Azafaros.
How can I track Azafaros secondary market activity?
Caplight tracks bids, offers, and trades in Azafaros's shares on secondary markets.